| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.4M | — | +122.2% |
| Cost of Revenue | $2.7M | — | +119.2% |
| Gross Profit | $687K | — | +135.3% |
| R&D Expense | $4.8M | — | +17.3% |
| SG&A Expense | $4.7M | — | -4.5% |
| Operating Income | -$14.0M | — | -22.0% |
| Net Income | -$13.7M | — | -22.6% |
| EPS (Basic) | -$0.16 | — | +27.3% |
| EPS (Diluted) | -$0.16 | — | +27.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $11.4M | +27.1% | -8.2% |
| Short-term Investments | $30.2M | -33.3% | +120.4% |
| Accounts Receivable | $2.4M | +9.8% | +50.7% |
| Inventory | $3.0M | -10.6% | +7.6% |
| Current Assets | $48.6M | -20.9% | +51.2% |
| Total Assets | $56.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$12.3M | — | -40.3% |
| Capital Expenditures | $194K | — | -46.0% |
| Investing Cash Flow | $14.8M | — | +768.3% |
| Financing Cash Flow | $506K | — | +0.0% |
| Free Cash Flow | -$12.5M | — | -36.9% |
| +46.0% |
| Current Liabilities | $9.4M | -11.8% | +28.2% |
| Total Liabilities | $12.9M | -9.5% | +24.5% |
| Stockholders' Equity | $43.6M | -21.0% | +53.9% |